Cargando…
Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19
Autores principales: | Peterson, Danielle, Damsky, William, King, Brett |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194643/ https://www.ncbi.nlm.nih.gov/pubmed/32344070 http://dx.doi.org/10.1016/j.jaad.2020.04.097 |
Ejemplares similares
-
The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Peterson, Danielle, et al.
Publicado: (2020) -
Reply: Potential role of Janus kinase inhibitors in COVID-19
por: Napolitano, Maddalena, et al.
Publicado: (2020) -
When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection
por: Damsky, William, et al.
Publicado: (2020) -
Blistering exanthems in the times of monkeypox—Keep calm and do not panic!
por: Mehta, Nikhil, et al.
Publicado: (2023) -
Reply to: Do interleukin 17 inhibitors increase risk of respiratory tract infections?
por: Blauvelt, Andrew, et al.
Publicado: (2020)